Treating Gastric Cancer Using TTFields Combined with XELOX, FOLFOX or the Individual Constituents Thereof
AssigneeNovocure GmbH
InventorsEinav ZEEVI, Karnit GOTLIB, Rosa S. SHNAIDERMAN, Moshe GILADI, Uri WEINBERG
Life of this patent
Estimating the term…
Abstract
Methods of treating gastric cancer and reducing the viability of gastric cancer cells by administering folinic acid, fluorouracil, and oxaliplatin to a subject, and applying an alternating electric field to a target region of the subject are provided. In some instances, chemotherapy such as XELOX, FOLFOX and individual components thereof are administered to a subject followed by applying an alternating electric field to the subject.
Claims16
A method of treating gastric cancer in a subject, the method comprising:
- administering oxaliplatin and capecitabine to the subject;
- and
- applying an alternating electric field to a target region of the subject, the alternating electric field having a frequency between 100 and 400 kHz.
A method of reducing viability of gastric cancer cells, the method comprising:
- administering oxaliplatin and capecitabine to the cancer cells;
- and
- applying an alternating electric field to the cancer cells, the alternating electric field having a frequency between 100 and 400 kHz.
Dependencies are inferred from the claim text.